SCB
RMD icon

Saudi Central Bank’s ResMed RMD Stock Holding History

Saudi Central Bank’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
10,198
+4,810
+89% +$997K 0.03% 330
2026
Q1 		$1.21M Buy
+5,388
New +$1.34M 0.03% 285
2025
Q2 		– Sell
-58
Closed -$13K – 441
2025
Q1 		$13K Buy
+58
New +$13.5K 0.07% 261

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Saudi Central Bank's RMD Position: Q2 2026 in Review

Saudi Central Bank increased its ResMed (RMD) stake by 89% in Q2 2026, buying an estimated $997K and bringing the position to 10,198 shares worth $1.99M. The position accounts for 0.03% of the portfolio, ranked #330.

Saudi Central Bank first reported a position in RMD in Q1 2025 and has held it in 3 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Saudi Central Bank held 10,198 shares of ResMed worth $1.99M as of Q2 2026.
  • Saudi Central Bank bought 4,810 ResMed shares in Q2 2026, an estimated $997K.
  • ResMed made up 0.03% of Saudi Central Bank's portfolio in Q2 2026, its #330 holding.
  • Saudi Central Bank first reported a position in ResMed in Q1 2025 and has held it in 3 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.